Boehringer Ingelheim Roxane recalls

Boehringer Ingelheim Roxane has 15 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 21 Oct 2015. The most frequent reason is potency & assay.

Total recalls15since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 21 Oct 2015

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 5 33%Class III 10 67%

Why boehringer ingelheim roxane is recalled

Product types

Brands

By year

2015427%
2014533%
2013533%
201217%

All boehringer ingelheim roxane recalls, newest first

15 total

Reported	Class	Recall	Company	Reason	Where
21 Oct 2015Drug	CLASS III	Furosemide Tablets USP, 40 mg recalled by Boehringer Ingelheim RoxaneFurosemide	Boehringer Ingelheim Roxane	Manufacturing (CGMP) Deviations	Nationwide
21 Oct 2015Drug	CLASS III	Furosemide Tablets USP, 20 mg recalled by Boehringer Ingelheim RoxaneFurosemide	Boehringer Ingelheim Roxane	Manufacturing (CGMP) Deviations	Nationwide
5 Aug 2015Drug	CLASS II	Combivent Respimat (ipratropium bromide recalledCombivent Respimat	Boehringer Ingelheim Roxane	Other	Nationwide
3 Jun 2015Drug	CLASS II	Acarbose Tablets 50 mg a) Unit Dose Tablets per, b) recalledAcarbose	Boehringer Ingelheim Roxane	Potency & Assay	Nationwide
6 Aug 2014Drug	CLASS III	Oxycodone Hydrochloride C II Oral Solution USP, 5 mg/ Vial recalled	Boehringer Ingelheim Roxane	Potency & Assay	Nationwide
16 Jul 2014Drug	CLASS II	Calcitriol Oral Solution 1 mcg/mL recalledCalcitriol	Boehringer Ingelheim Roxane	Potency & Assay	Nationwide
14 May 2014Drug	CLASS III	Mercaptopurine Tablets USP, 50 mg recalledMercaptopurine	Boehringer Ingelheim Roxane	Other	Nationwide
14 May 2014Drug	CLASS III	Azathioprine Tablets USP, 50 mg recalled by Boehringer Ingelheim Roxane	Boehringer Ingelheim Roxane	Other	Nationwide
16 Apr 2014Drug	CLASS III	Spiriva HandiHaler (tiotropium bromide inhalation powder) recalledSpiriva	Boehringer Ingelheim Roxane	Potency & Assay	Nationwide
18 Dec 2013Drug	CLASS III	Oxcarbazepine Tablets, 150 mg recalled by Boehringer Ingelheim Roxane	Boehringer Ingelheim Roxane	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.